Shailendra Tyagi, CEO (education and stationery products business division) ITC, tells BV Mahalakshmi during an interview that the Classmate Pulse 3D Notebook marks ITC Classmate’s commitment towards constantly enhancing us
According to local reports, projects worth over Rs 20,000 crore were awarded to Singapore and few other infrastructure companies for urban planning and development, transportation, waste and water management, power, building
CVR Navayuga Group, along with family and friends, own 91% of Krishnapatnam Port and the balance 9.4% is held by the London-based equity firm 3i Group. The total amount invested for development of the port is in excess of Rs
The Adani Group had signed an MoU with the AP government in January with a committed investment of Rs 70,000 crore for the next 20 years. Under this MoU, the company had planned to set up three green data centres and a 5 GW s
IKEA is transforming globally to become more accessible, affordable and sustainable. Our ambition is to create a more digitally-enabled IKEA to be able to reach many customers where they are and when they want to shop.
The order issued by the department of industry, infrastructure, investment and commerce made it clear that the government reserved the liberty to claim compensation for the damages suffered by the government from Machilipatna
The Andhra Pradesh government will soon reopen talks with officials of the World Bank and the Asian Infrastructure Investment Bank, seeking support for construction of the state's capital city, Amaravati, and a few other inf
Billed as one of the largest FDI in the automobile sector, the company had said it would employ 3,000 people and ramp up production in a gradual manner, starting with 100,000 units in the first year in a single shift.
Dubai Startup Hub, an initiative of Dubai Chamber of Commerce and Industry, is set to become a global innovation hub for the next generation technologies, wooing entrepreneurs from India with $100 million start-up fintech fun
Pharma major Novartis is investing in data and digital technologies to explore potential benefits, including developing drugs based on unique biomarkers of patients who are not part of clinical trials.